27
https://pubmed.ncbi.nlm.nih.gov/38091844
The abstract describes the development of SurvIAE, a pipeline using autoencoders and Explainable Artificial Intelligence to stratify prognosis and derive a gene-based signature for Diffuse Large B-Cell Lymphoma, outperforming current risk assessment methods.
